Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03083379 · ClinicalTrials.gov registry record · NA

Pilot Evaluation Comparing Regional Distribution of Ventilation During Lung Expansion Therapy

A NA study of Ventilation and Atelectasis, sponsored by University of Virginia.

Completed
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT03083379 is a NA study of Ventilation and Atelectasis that has completed, run by University of Virginia. The registered enrollment target is 30 participants, below the 530-participant average among 4 other Ventilation trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03083379, a NA study of Ventilation and Atelectasis, has completed, sponsored by University of Virginia.

COMPLETED
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

The primary purpose of this study is to determine if there is a significant difference in regional distribution of ventilation when comparing eupneic tidal ventilation with Incentive Spirometry (I.S.) and EzPAP® lung expansion therapy in healthy adult human subjects. Electrical impedance tomography (EIT) will be used to measure regional distribution of ventilation during resting tidal ventilation and during lung expansion therapy.

Interventions

  • DEVICE Volumetric Incentive Spirometry
  • DEVICE EzPAP® POSITIVE AIRWAY PRESSURE

Study Locations (1)

Virginia

  • University of Virginia Medical Center - Charlottesville

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2017-03-06
Est. Completion 2017-04-21
Phase NA

Sponsor

University of Virginia

449 total trials

What the Registry Record Tells You About NCT03083379

The ClinicalTrials.gov registry entry for NCT03083379 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 530-participant average among 4 other Ventilation trials with a reported enrollment target (94% lower). The listed sponsor is University of Virginia, which has 449 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Ventilation appearing as the primary indexed condition, and to 2 interventions - of which Volumetric Incentive Spirometry is the first listed.

NCT03083379 reports 1 study location spanning 1 distinct geographic area - top geographies include Virginia.

Frequently Asked Questions

What is clinical trial NCT03083379 about?

NCT03083379 is a clinical study titled "Pilot Evaluation Comparing Regional Distribution of Ventilation During Lung Expansion Therapy". The primary purpose of this study is to determine if there is a significant difference in regional distribution of ventilation when comparing eupneic tidal ventilation with Incentive Spirometry (I.S.) and EzPAP® lung expansion therapy in healthy adult human subjects. Electrical impedance tomography ...

What is the current status of trial NCT03083379?

This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2017-03-06. Estimated completion is 2017-04-21.

What conditions does trial NCT03083379 study?

This clinical trial studies the following conditions: Ventilation, Atelectasis, Breathing.

What interventions are being tested in trial NCT03083379?

The interventions under investigation include: Volumetric Incentive Spirometry (DEVICE), EzPAP® POSITIVE AIRWAY PRESSURE (DEVICE).

Who is sponsoring clinical trial NCT03083379?

This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03083379 being conducted?

This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Ventilation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.